CRIS Current Research Information System

FAROLFI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.294
NA - Nord America 1.352
EU - Europa 754
SA - Sud America 130
AF - Africa 87
OC - Oceania 2
Totale 4.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.325
SG - Singapore 759
VN - Vietnam 561
CN - Cina 515
HK - Hong Kong 215
IT - Italia 158
DE - Germania 112
BR - Brasile 92
GB - Regno Unito 80
FR - Francia 78
SE - Svezia 62
KR - Corea 55
NL - Olanda 51
IN - India 50
FI - Finlandia 42
CI - Costa d'Avorio 33
IE - Irlanda 32
RU - Federazione Russa 31
JP - Giappone 25
AT - Austria 19
ID - Indonesia 19
AR - Argentina 17
SC - Seychelles 16
CH - Svizzera 14
BD - Bangladesh 13
BG - Bulgaria 13
BE - Belgio 12
ES - Italia 12
TH - Thailandia 12
CA - Canada 11
PH - Filippine 11
UA - Ucraina 11
IQ - Iraq 9
MX - Messico 9
TG - Togo 9
ZA - Sudafrica 9
JO - Giordania 7
TW - Taiwan 7
CL - Cile 6
EC - Ecuador 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CO - Colombia 4
MY - Malesia 4
CZ - Repubblica Ceca 3
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
IR - Iran 3
LT - Lituania 3
PK - Pakistan 3
PL - Polonia 3
TN - Tunisia 3
TR - Turchia 3
VE - Venezuela 3
AU - Australia 2
IL - Israele 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
LY - Libia 2
NG - Nigeria 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
PA - Panama 1
PY - Paraguay 1
QA - Qatar 1
TJ - Tagikistan 1
TZ - Tanzania 1
Totale 4.619
Salva come PNG Salva come JPEG
Città #
Singapore 531
San Jose 219
Ashburn 206
Hong Kong 199
Ho Chi Minh City 154
Hanoi 151
Santa Clara 128
Hefei 125
Beijing 70
Chandler 70
Boardman 60
Southend 55
Seoul 47
Fairfield 45
Helsinki 39
Lauterbourg 38
Los Angeles 35
Abidjan 33
Ann Arbor 32
Dublin 32
Council Bluffs 30
Dallas 28
Princeton 26
Da Nang 23
Houston 23
Buffalo 22
Seattle 22
Frankfurt am Main 21
Rome 20
Wilmington 20
Tokyo 19
Bologna 18
Woodbridge 18
Haiphong 17
Cambridge 16
New York 15
Bengaluru 14
Falkenstein 14
Munich 14
Nuremberg 14
Guangzhou 13
Jakarta 13
Redondo Beach 13
Sofia 13
Shanghai 12
Milan 11
Bern 10
São Paulo 10
Turin 10
Brussels 9
Lomé 9
Vienna 9
Bangkok 8
Can Tho 8
Hải Dương 8
London 8
Shenzhen 8
Amman 7
Chicago 7
Düsseldorf 7
Hangzhou 7
Shijiazhuang 7
Berlin 6
Brooklyn 6
Denver 6
Des Moines 6
Jacksonville 6
Montescudo 6
Nanjing 6
Padova 6
Rach Gia 6
Stockholm 6
Baghdad 5
Changsha 5
Jinan 5
Mexico City 5
Modena 5
Montreal 5
Phoenix 5
Rio de Janeiro 5
Tashkent 5
Tianjin 5
Tân Tiến 5
Wuhan 5
Barcelona 4
Belo Horizonte 4
Boston 4
Dongguan 4
Genoa 4
Harbin 4
Jiaxing 4
Ninh Bình 4
Paris 4
Salvador 4
Thái Bình 4
Vĩnh Long 4
Westminster 4
Atlanta 3
Belém 3
Biên Hòa 3
Totale 3.051
Salva come PNG Salva come JPEG
Nome #
Immunotherapy and its development for gynecological (Ovarian, endometrial and cervical) tumors: From immune checkpoint inhibitors to chimeric antigen receptor (car)-T cell therapy 188
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 178
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients 169
Endometrioid Cancer Associated With Endometriosis: From the Seed and Soil Theory to Clinical Practice 153
Early Detection of Cardiotoxicity in Chemotherapy-Treated Patients from Real-time 3D Echocardiography 147
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 144
Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors 142
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations. 140
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 136
Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients? 135
The interplay between inflammation, anti-angiogenic agents, and immune checkpoint inhibitors: Perspectives for renal cell cancer treatment 130
Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma 130
Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial 123
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients 123
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 116
Taxanes as a Risk Factor for Acute Adverse Reactions to Iodinated Contrast Media in Cancer Patients 113
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 110
Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors 109
Erratum to “Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life” [Eur J Cancer 69 (2016) 110–118] 106
Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer 101
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide 92
Baseline Plasma Tumor DNA (ctDNA) Correlates with PSA Kinetics in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide 91
Hydroxychloroquine as Prophylaxis for COVID-19: A Review 81
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial 76
Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population? 67
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 66
Immunotherapy for prostate cancer: Where we are headed 65
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 64
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer 64
Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors 64
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma 63
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy 60
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial 59
Perspectives, Challenges, and Advances in Therapeutic Strategies for Gynecological Malignant Tumors 59
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer 57
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature 56
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy? 55
Ipilimumab in advanced melanoma: Reports of long-lasting responses 55
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 52
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer 51
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy 51
Hormonal receptor, human epidermal growth factor receptor-2, and ki67 discordance between primary breast cancer and paired metastases: Clinical impact 50
Glutathione, glutathione disulfide, and S-glutathionylated proteins in cell cultures 49
Immune-checkpoint inhibitors and the importance of concomitant medications: focus on antibiotics 47
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS 47
Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients 47
Palbociclib (PD 0332991): Targeting the cell cycle machinery in breast cancer 47
Immune system and DNA repair defects in ovarian cancer: Implications for locoregional approaches 46
Bevacizumab as maintenance treatment in patients with ovarian cancer: Wait for BRCA testing 46
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review 46
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions 45
Progress with palbociclib in breast cancer: Latest evidence and clinical considerations 44
Metastatic bone disease in the era of bone-targeted therapy: Clinical impact 40
Risk of Myelodysplastic Syndrome and Acute Myeloid Leukemia related to PARP inhibitor Maintenance Line in Real-world Ovarian Cancer Patients 40
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study 36
Psychosocial issues in long-term survivors of testicular cancer 35
Sorafenib for the treatment of breast cancer 25
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma 15
null 2
Totale 4.748
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.802
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 5 5 8
2021/2022200 10 3 5 17 15 10 10 16 9 24 40 41
2022/2023283 23 37 8 37 20 24 10 12 66 7 16 23
2023/2024166 11 13 12 2 5 18 6 4 70 3 16 6
2024/20251.184 67 160 109 111 181 70 39 39 13 81 46 268
2025/20262.647 257 250 199 206 316 88 352 215 558 206 0 0
Totale 4.748